M.Pharm

The Institute for Stem Cell Biology and Regenerative Medicine (inStem), is a state-of-the-art research institute in Bangalore, India, dedicated to the study of stem cell and regenerative biology. An autonomous institute funded by the Dept of Biotechnology, Govt. of India, inStem emphasizes collaborative research in stem cell biology. inStem’s mandate to allow this cross-disciplinary, multi-pronged approach to research, straddles the divide between clinical and laboratory research in stem cell biology. In trying to answer intractable and challenging questions that face the field, inStem seeks to rewrite the paradigm of the research institute: without barriers and across disciplines.

Post : Animal Care and Resource Center FACILITY ASSISTANTs

Eisai Inc. is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Established in 1995, Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business with sales of approximately $3.9 billion in fiscal year 2009 (year ending March 31, 2010).

Post : Health Care Manager

Apotex is a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. We are the 7th largest generic pharmaceutical company globally with more than 12,000 employees and estimated sales of approximately $3 billion. Our fully integrated operation is comprised of four lines of business: Global Generics; Apobiologix; Global Active Pharmaceutical Ingredients (API); and ApoPharma (Innovative Products). With our worldwide manufacturing sites, Apotex can produce up to 24 billion dosages per year. We produce 300 medicines in 4,000 dosages and formats that are exported to 115 countries. Apotex will spend $2 billion over the next 10 years on research and development.

Post : Sr. Associate/Associate-Regulatory Affairs

Marathwada region was ruled by the Nizam and even uttering the word "Bharat" was a crime. Still, with great nationalistic spirit our beloved leaders named the sanstha as "Bharat Shikshan Sanstha" and many times they had to go through political harassment due to it. Reverend freedom fighter Late Tatyaraoji More, the founder and former Secretary and his colleagues established Bharat Vidyalaya in the same year. They knew that education alone is the means to break the shackles of ignorance and poverty; education alone can bring enlightenment and education alone can make nation’s freedom and democracy successful.

National Chemical Laboratory (CSIR-NCL), Pune, established in 1950, is a constituent laboratory of Council of Scientific and Industrial Research (CSIR). CSIR-NCL is a science and knowledge based research, development and consulting organization. It is internationally known for its excellence in scientific research in chemistry and chemical engineering as well as for its outstanding track record of industrial research involving partnerships with industry from concept to commercialization.

Applications are invited in the prescribed Proforma for filling up of position(s) of Project Assistant on a purely temporary basis.

Post : PA-II

Defence Institute of Bio-Energy Research (DIBER) under the aegis of DRDO is engaged in Research & Development in the area of bio-resource utilization for bio-energy. herbal product development and application of genetic engineering for crop improvement. DIBER provides excellent opportunity to young and motivated researchers to pursue career in basic and applied field of Life Science research with state of art research facilities.

Applications are invited from young and motivated candidates for the post of Junior Research Fellows to work in ongoing and future research projects at DIBER and its stations and project sites.

Post : Junior Research Fellows

Apotex is a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. We are the 7th largest generic pharmaceutical company globally with more than 12,000 employees and estimated sales of approximately $3 billion. Our fully integrated operation is comprised of four lines of business: Global Generics; Apobiologix; Global Active Pharmaceutical Ingredients (API); and ApoPharma (Innovative Products). With our worldwide manufacturing sites, Apotex can produce up to 24 billion dosages per year. We produce 300 medicines in 4,000 dosages and formats that are exported to 115 countries. Apotex will spend $2 billion over the next 10 years on research and development.

Post : Clinical Research Associate- BEC